Target intelligence / Profile preview

Fc gamma receptor I, II, and III (FcγRI, FcγRII, FcγRIII)

Target
FcγRI, FcγRII, FcγRIII
Molecular classification
Receptor, Immunoglobulin superfamily
01

Overview

Fc gamma receptors I, II, and III are a family of cell surface receptors expressed primarily on phagocytes such as macrophages, neutrophils, monocytes, and dendritic cells. They bind to the constant region (Fc) of immunoglobulin G (IgG) antibodies that have opsonized pathogens or target cells. This interaction mediates key effector functions including phagocytosis, where opsonized particles are engulfed by phagocytes; antibody-dependent cellular cytotoxicity; endocytosis; and modulation of inflammatory responses[1][3][4]. Each subtype has unique structural features and signaling mechanisms. For example: * FcγRI has high affinity for monomeric IgG. * FcγRIIA contains an intrinsic ITAM motif in its cytoplasmic tail that initiates signaling upon crosslinking. * FcγRIIB is inhibitory due to an ITIM motif. * FcγRIIIA/IIIB require association with a common γ-chain containing ITAMs for signal transduction. Upon engagement by immune complexes or therapeutic antibodies' Fc domains, these receptors trigger intracellular signaling cascades involving tyrosine phosphorylation motifs like ITAMs. This leads to recruitment and activation of kinases such as Syk and PI3K—ultimately resulting in actin remodeling required for engulfment/phagosome formation or triggering cell-mediated killing mechanisms[1][3][5]. These receptors play central roles in host defense against infection but are also implicated in autoimmune diseases when dysregulated. Therapeutically engineered monoclonal antibodies often exploit these pathways to enhance clearance of target cells through improved binding affinity with specific Fc gamma receptor subtypes[2]. Overactivation can lead to adverse inflammatory reactions. "An important function of Fc gamma receptors is the ingestion or phagocytosis of IgG sensitized cells... isoforms from each class can mediate phagocytosis although requirements differ"[1]. "The interaction between Fc-FcγR mediates intracellular protective activity against monoclonal antibody... involvement induces multipotent pro-inflammatory functions"[4].

Other names
CD64 (FcγRI)CD32 (FcγRII)CD16 (FcγRIII)IgG Fc receptor
02

Mechanism of action

Engagement of the receptor by the IgG-Fc region triggers phagocytosis or ADCC[1][3][4] Crosslinking leads to ITAM phosphorylation and downstream activation of kinases such as Syk[1][3][5]

03

Biological functions

Immune responsePhagocytosisAntibody-dependent cellular cytotoxicity (ADCC)Endocytosis of immune complexes
04

Disease associations

InflammationInfectionAutoimmune disease
05

Safety considerations

Risk of excessive inflammation or cytokine release syndrome due to overactivation[4]Potential for off-target effects in antibody therapies targeting these pathways
06

Interacting drugs

Monoclonal antibodies with engineered Fc regions (e.g., rituximab, trastuzumab—these interact via their IgG Fc domains)

1 more in the full profile.

07

Biomarkers

Expression levels of CD64/CD32/CD16 on myeloid cells can serve as biomarkers for immune activation or inflammation[7]

Beyond the preview

Go deeper on Fc gamma receptor I, II, and III (FcγRI, FcγRII, FcγRIII).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fc gamma receptor I, II, and III (FcγRI, FcγRII, FcγRIII).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call